Citations

Clear

371 citation(s) found for "Cho, B".

Novel Privacy Considerations for Large Scale Proteomics
Yu, Bing , Gorbet, Betty A., Lange, Leslie A. , Pratte, Katherine , Coors, Marilyn E., Ortega, Victor E. , Gerzsten, Robert E., Ngo, Debby , O’Neal, Wanda K. , Meyers, Deborah A. , Bleecker, Eugene R., Banaei‐Kashani, Farnoush , Guo, Claire, O'Neal, Wanda K , Hill, Andrew , LITKOWSKI, ELIZABETH M. , Manichaikul, Ani , Kechris, Katerina , DeCamp, Matthew W. , Rich, Stephen S. , Rotter, Jerome I. , Clish, Clary B. , Curtis, Jeffrey L. , Hu, Xiaowei , Hobbs, Brian D. , Cho, Michael H. , Bowler, Russell P.

Mayo Clinic

No container title available | November 3, 2022 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.21203/rs.3.rs-2160242/v1 Get It

Abstract Privacy protection is a core principle of genomic but not proteomic research. We identified independent single nucleotide polymorphism (SNP) quantitative trait loci (pQTL) from COPDGene and Jackson Heart Study (JHS), calculated continuous protein level genotype probabilities, and then applied a naïve Bayesian approach to match proteomes to genomes for 2,812 independent subjects from COPDGene, JHS, SubPopulations and InteRmediate Outcome Measures In COPD Study (SPIROMICS) and Multi-Ethnic Study of Atherosclerosis (MESA). We were able to correctly match 90%-95% of proteomes to their correct genome and for 95%-99% we could match the proteome to the 1% most likely genome. The accuracy of matching in subjects with African ancestry was lower (~ 60%) unless training included diverse subjects. With larger profiling (SomaScan 5K) in the Atherosclerosis Risk Communities (ARIC) correct identification was > 99% even in mixed ancestry populations. When serial proteomes are available, the matching algorithm can be used to identify and correct mislabeled samples. This work also demonstrates the importance of including diverse populations in omics research and that large proteomic datasets (> 1,000 proteins) can be accurately linked to a specific genome through pQTL knowledge and should not be considered unidentifiable.
Brentuximab Vedotin with Chemotherapy in Pediatric High-Risk Hodgkin’s Lymphoma
Castellino, Sharon M. , Pei, Qinglin , Parsons, Susan K. , McCarten, Kathleen M. , Cho, Steve , Wu, Yue , Punnett, Angela , Henderson, Tara O. , Charpentier, Anne-Marie , Keller, Frank G. , Kelly, Kara M. , McCarten, Kathleen, Horton, Terzah, Dave, Hema, K Parsons, Susan , Castellino, Sharon , Hodgson, David , Horton, Terzah M. , Dave, Hema , Hoppe, Bradford S.

Mayo Clinic

New England Journal of Medicine | November 2, 2022 | Volume: 387 | Issue: 18 | Pages: 1649-1660

10.1056/nejmoa2206660 | PMID 36322844 Get It

T087: Brentuximab vedotin (Bv) Demonstrates Superior Event-Free Survival in Pediatric High-Risk Hodgkin Lymphoma
Pei, Qinglin , McCarten, Kathleen M. , Cho, Steve , Wu, Yue , Punnett, Angela , Henderson, Tara O. , Charpentier, Ann-Marie, Keller, Frank G. , Kelly, Kara M. , Castellino, Sharon M. , Parsons, Susan K. , Hodgson, David , Horton, Terzah M. , Dave, Hema , Hoppe, Bradford S.

Mayo Clinic

HemaSphere | October 10, 2022 | Volume: 6 | Issue: No issue available | Pages: 40-40

10.1097/01.hs9.0000890916.12776.84 Get It

A lipoglycopeptide antibiotic for Gram-positive biofilm-related infections
Blaskovich, Mark A. T. , Hansford, Karl A. , Butler, Mark S. , Ramu, Soumya , Kavanagh, Angela M. , Prasetyoputri, Anggia , Pitt, Miranda E. , Huang, Johnny X. , Lindahl, Fredrik, Ziora, Zyta M. , Bradford, Tanya A. , Muldoon, Craig, Premraj, Rajaratnam , Pelingon, Ruby , Edwards, David J. , Amado, Maite , Woischnig, Anne-Kathrin , Breidenstein, Elena B. M. , Stincone, Anna, Karau, Melissa J. , Greenwood‐Quaintance, Kerryl E. , Wootton, Mandy , James, Meagan L. , Hutton, M. , Mahdi, Layla K. , Trott, Darren J. , Wu, Xiaoqian, Niles, Samantha , Lewis, Kim , Yim, Juwon , Rice, Seth, Rybak, Michael J. , Ishmael, Chad R. , Hori, Kellyn R. , Francis, Kevin P. , Jarrad, Angie M , Prasetyoputri, Anggia , Pitt, Miranda E , Huang, Johnny X , Ziora, Zyta M , Bradford, Tanya , Rajaratnam, Premraj , Pelingon, Ruby , Zhang, Bing , Elliott, Alysha G , Zuegg, Johannes , Coin, Lachlan , Khanna, Nina , Stincone, Anna , Mason, Clive , Cho, Hye-Kyung , Karau, Melissa , Greenwood-Quaintance, Kerryl , Patel, Robin , Wootton, Mandy , James, Meagan L , Hutton, Melanie L , Lyras, Dena , Ogunniyi, Abiodun D , Mahdi, Layla K , Niles, Samantha , Lewis, Kim , Smith, Jordan R , Barber, Katie E , Rybak, Michael J , Ishmael, Chad R , Hori, Kellyn R , Bernthal, Nicholas M , Francis, Kevin P , Paterson, David L. , Cooper, Matthew A , Blaskovich, Mark A T , Edwards, David J., Khan, Nawaz, Patel, Robin , Roberts, Jason A

Mayo Clinic

Science Translational Medicine | September 14, 2022 | Volume: 14 | Issue: 662 | Pages: No page available

10.1126/scitranslmed.abj2381 | PMID 36103517 Get It

Drug-resistant Gram-positive bacterial infections are still a substantial burden on the public health system, with two bacteria ( Staphylococcus aureus and Streptococcus pneumoniae ) accounting for over 1.5 million drug-resistant infections in the United States alone in 2017. In 2019, 250,000 deaths were attributed to these pathogens globally. We have developed a preclinical glycopeptide antibiotic, MCC5145, that has excellent potency (MIC 90 ≤ 0.06 μg/ml) against hundreds of isolates of methicillin-resistant S. aureus (MRSA) and other Gram-positive bacteria, with a greater than 1000-fold margin over mammalian cell cytotoxicity values. The antibiotic has therapeutic in vivo efficacy when dosed subcutaneously in multiple murine models of established bacterial infections, including thigh infection with MRSA and blood septicemia with S. pneumoniae , as well as when dosed orally in an antibiotic-induced Clostridioides difficile infection model. MCC5145 exhibited reduced nephrotoxicity at microbiologically active doses in mice compared to vancomycin. MCC5145 also showed improved activity against biofilms compared to vancomycin, both in vitro and in vivo, and a low propensity to select for drug resistance. Characterization of drug action using a transposon library bioinformatic platform showed a mechanistic distinction from other glycopeptide antibiotics.
Exercise Training Attenuates Pulmonary Inflammation In High-fat High-carbohydrate Induced NAFLD
Johnson, Bruce D. , Watt, Kymberly D. , Han, Tae‐Kyung, Kim, Chul-Ho, Cho, Jinkyung , Niven, Alexander S. , Kim, Chul-Ho

Mayo Clinic

Medicine & Science in Sports & Exercise | September 6, 2022 | Volume: 54 | Issue: 9S | Pages: 652-652

10.1249/01.mss.0000883212.78575.55 Get It

Safety and Efficacy of Transoral Robotic Thyroidectomy for Thyroid Tumor: A Systematic Review and Meta-Analysis
Kang, Yun Jin , Cho, Jinhee , Stybayeva, Gulnaz, Hwang, Se Hwan , Hwang, Se Hwan , Stybayeva, Gulnaz

Mayo Clinic

Cancers | August 31, 2022 | Volume: 14 | Issue: 17 | Pages: 4230

10.3390/cancers14174230 | PMID 36077768 Get It

Background: To assess the safety and effectiveness of transoral robotic thyroidectomy (TORT) in thyroid tumor. Methods: PubMed, Embase, Web of Science, SCOPUS, Cochrane database, and Google Scholar up to June 2022. Studies comparing outcomes and complications between TORT and control groups (robotic bilateral axillo-breast, trans-axillary, postauricular approach, conventional open thyroidectomy (OT), and transoral endoscopic approach) were analyzed. Results: Ten studies of 1420 individuals. The operative time (SMD 1.15, 95%CI [0.48; 1.89]) was significantly longer and the number of retrieved lymph nodes (LNs) (SMD −0.27, 95%CI [−0.39; −0.16]) was fewer in TORT than in the control group. The postoperative cosmetic satisfaction score (SMD 0.60, 95%CI [0.28; 0.92]) was statistically higher in TORT than in the control group. In subgroup analysis, there was no significant difference between robotic surgeries. However, TORT had significantly longer operative times (SMD 2.08, 95%CI [0.95; 3.20]) and fewer retrieved LNs (SMD −0.32, 95%CI [−0.46; −0.17]) than OT. TORT satisfied significantly more patients in cosmetic view. However, it increased hospitalization days and postoperative pain on the operation day and first day compared to OT. Conclusions: TORT is not inferior to other robotic-assisted approaches. Its operation time and hospitalization days are longer and postoperative pain is greater than OT, although its cosmetic satisfaction is high.
Comprehensive Characterization of the Multiple Myeloma Immune Microenvironment Using Integrated scRNA-seq, CyTOF, and CITE-seq Analysis
Jayasinghe, Reyka G. , Lee, Brian , Bhasin, Swati S. , Pilcher, William , Dasari, Surendra , Fiala, Mark A. , Pita-Juárez, Yered , Strausbauch, Michael, Kelly, Geoffrey , Thomas, Beena , Kumar, Shaji , Anderson, Emilie, Wendl, Michael C. , Dawson, Travis , D’souza, Darwin , Cheloni, Giulia , Li, Ying , Dhodapkar, Kavita M. , Vij, Ravi , Vlachos, Ioannis S. , Mehr, Shaadi , Hamilton, Mark , Auclair, Daniel , Kourelis, Taxiarchis , Avigan, David , Dhodapkar, Madhav V. , Gnjatic, Sacha , Ding, Li , Jayasinghe, Reyka G , Bhasin, Swati S , Pilcher, William , Dasari, Surendra , Fiala, Mark A , Pita-Juarez, Yered , Kumar, Shaji K , Dawson, Travis , Oh, Stephen T , Li, Ying , Rahman, Adeeb H , Dhodapkar, Kavita M , Hamilton, Mark , Auclair, Daniel , Dhodapkar, Madhav V , Gnjatic, Sacha , Bhasin, Manoj K , Ding, Li , Vlachos, Ioannis S , Yao, Lijun , Doxie, Deon Bryant , Gonzalez‐Kozlova, Edgar , Thomas, Beena E., Cho, Hearn Jay , Oh, Stephen T. , DiPersio, John F. , Kim-Schulze, Seunghee

Mayo Clinic

Cancer Research Communications | August 31, 2022 | Volume: 2 | Issue: 10 | Pages: 1255-1265

10.1158/2767-9764.crc-22-0022 | PMID 36969740 Get It

As part of the Multiple Myeloma Research Foundation (MMRF) immune atlas pilot project, we compared immune cells of multiple myeloma bone marrow samples from 18 patients assessed by single-cell RNA sequencing (scRNA-seq), mass cytometry (CyTOF), and cellular indexing of transcriptomes and epitopes by sequencing (CITE-seq) to understand the concordance of measurements among single-cell techniques. Cell type abundances are relatively consistent across the three approaches, while variations are observed in T cells, macrophages, and monocytes. Concordance and correlation analysis of cell type marker gene expression across different modalities highlighted the importance of choosing cell type marker genes best suited to particular modalities. By integrating data from these three assays, we found International Staging System stage 3 patients exhibited decreased CD4+ T/CD8+ T cells ratio. Moreover, we observed upregulation of RAC2 and PSMB9, in natural killer cells of fast progressors compared with those of nonprogressors, as revealed by both scRNA-seq and CITE-seq RNA measurement. This detailed examination of the immune microenvironment in multiple myeloma using multiple single-cell technologies revealed markers associated with multiple myeloma rapid progression which will be further characterized by the full-scale immune atlas project. Significance: scRNA-seq, CyTOF, and CITE-seq are increasingly used for evaluating cellular heterogeneity. Understanding their concordances is of great interest. To date, this study is the most comprehensive examination of the measurement of the immune microenvironment in multiple myeloma using the three techniques. Moreover, we identified markers predicted to be significantly associated with multiple myeloma rapid progression.
Septin‐5 and ‐7‐IgGs: Neurologic, Serologic, and Pathophysiologic Characteristics
Hinson, Shannon R., Honorat, Josephe A., Grund, Ethan M. , Clarkson, Benjamin D. , Miske, Ramona , Scharf, Madeleine, Zivelonghi, Cecilia , Al‐Lozi, Muhammad, Bucelli, Robert C. , Cho, Tracey , Grell, Jacquelyn A., López‐Chiriboga, A. Sebastian , Levin, Marc S., Merati, Melody, Montalvo, Mayra , Pittock, Sean J. , Wilson, Michael R. , Howe, Charles L. , Budhram, Adrian , Grell, Jacquelyn, Lopez-Chiriboga, A Sebastian , Pittock, S J , Wilson, Michael R , McKeon, Andrew , Howe, Charles L , Cho, Tracey A , Choi, Ellie, Levin, Marc, McKeon, Andrew

Mayo Clinic

Annals of Neurology | August 15, 2022 | Volume: 92 | Issue: 6 | Pages: 1090-1101

10.1002/ana.26482 | PMID 36053822 Get It

Background and ObjectivesWe sought to determine clinical significance of neuronal septin autoimmunity and evaluate for potential IgG effects.MethodsSeptin‐IgGs were detected by indirect immunofluorescence assays (IFAs; mouse tissue and cell based) or Western blot. IgG binding to (and internalization of) extracellular septin epitopes were evaluated for by live rat hippocampal neuron assay. The impact of purified patient IgGs on murine cortical neuron function was determined by recording extracellular field potentials in a multielectrode array platform.ResultsSeptin‐IgGs were identified in 23 patients. All 8 patients with septin‐5‐IgG detected had cerebellar ataxia, and 7 had prominent eye movement disorders. One of 2 patients with co‐existing septin‐7‐IgG had additional psychiatric phenotype (apathy, emotional blunting, and poor insight). Fifteen patients had septin‐7 autoimmunity, without septin‐5‐IgG detected. Disorders included encephalopathy (11; 2 patients with accompanying myelopathy, and 2 were relapsing), myelopathy (3), and episodic ataxia (1). Psychiatric symptoms (≥1 of agitation, apathy, catatonia, disorganized thinking, and paranoia) were prominent in 6 of 11 patients with encephalopathic symptoms. Eight of 10 patients with data available (from 23 total) improved after immunotherapy, and a further 2 patients improved spontaneously. Staining of plasma membranes of live hippocampal neurons produced by patient IgGs (subclasses 1 and 2) colocalized with pre‐ and post‐synaptic markers. Decreased spiking and bursting behavior in mixed cultures of murine glutamatergic and GABAergic cortical neurons produced by patient IgGs were attributable to neither antigenic crosslinking and internalization nor complement activation.InterpretationSeptin‐IgGs are predictive of distinct treatment‐responsive autoimmune central nervous system (CNS) disorders. Live neuron binding and induced electrophysiologic effects by patient IgGs may support septin‐specific pathophysiology. ANN NEUROL 2022;92:1090–1101
Tumor Infiltrating Lymphocytes in Multi-National Cohorts of Ductal Carcinoma In Situ (DCIS) of Breast
Badve, Sunil , Cho, Sanghee , Cao, Sha , Ghose, Soumya , Thike, Aye Aye , Tan, Puay Hoon , Ocal, Idris Tolgay, Generali, Daniele , Harris, Adrian L. , Ginty, Fiona , Gökmen‐Polar, Yesim , Badve, Sunil S , Generali, Daniele , Harris, Adrian L , Gökmen-Polar, Yesim , Lu, Xiaoyu , Zanconati, Fabrizio

Mayo Clinic

Cancers | August 14, 2022 | Volume: 14 | Issue: 16 | Pages: 3916

10.3390/cancers14163916 | PMID 36010908 Get It

Tumor-infiltrating lymphocytes (TILs) are prognostic in invasive breast cancer. However, their prognostic significance in ductal carcinoma in situ (DCIS) has been controversial. To investigate the prognostic role of TILs in DCIS outcome, we used different scoring methods for TILs in multi-national cohorts from Asian and European women. Self-described race was genetically confirmed using QC Infinium array combined with radmixture software. Stromal TILs, touching TILs, circumferential TILs, and hotspots were quantified on H&E-stained slides and correlated with the development of second breast cancer events (BCE) and other clinico-pathological variables. In univariate survival analysis, age older than 50 years, hormone receptor positivity and the presence of circumferential TILs were weakly associated with the absence of BCE at the 5-year follow-up in all cohorts (p < 0.03; p < 0.02; and p < 0.02, respectively, adjusted p = 0.11). In the multivariable analysis, circumferential TILs were an independent predictor of a better outcome (Wald test p = 0.01), whereas younger age was associated with BCE. Asian patients were younger with larger, higher grade, HR negative DCIS lesions, and higher TIL variables. The spatial arrangement of TILs may serve as a better prognostic indicator in DCIS cases than stromal TILs alone and may be added in guidelines for TILs evaluation in DCIS.
Genomic and phenomic landscape of clonal hematopoiesis in over a million ancestrally diverse participants
Uddin, Md Mesbah , Weinstock, Joshua S. , Niroula, Abhishek , Vlasschaert, Caitlyn , Koyama, Satoshi , Nakao, Tetsushi , Urbut, Sarah , Paruchuri, Kaavya , Silver, Alexander J. , Mack, Taralynn , Wong, Megan , Bhattacharya, Romit , Jorshery, Saman Doroodgar , Raddatz, Michael A. , Hornsby, Whitney , Kresge, Hailey A. , Cho, Kelly , Sun, Yan V. , Pyarajan, Saiju , Chen, Yii‐Der Ida , Sheu, Wayne H-H , Hung, Yi‐Jen , Hidalgo, Bertha , Fornage, Myriam , Kaplan, Robert C., Williams, L. Keoki , Province, Mike , Kardia, Sharon, Peyser, Patricia A., Yanek, Lisa R. , Becker, Lewis C. , Meyers, Deborah A. , Naseri, Take, Barnes, Kathleen C. , Redline, S S, Schwartz, D A, Shoemaker, M. Benjamin , Palmer, Nicholette D., Bowden, Donald W., Kumar, Rajesh, Nj, Smith, Floyd, James, Tracy, Russell, Bis, Joshua C. , SS, Rich, Boerwinkle, Eric, Wang, Zhe, Silverman, Edwin K. , Auer, Paul L. , Reiner, Alexander P. , Ebert, Benjamin L. , Natarajan, Pradeep , Uddin, Md M , Niroula, Abhishek , Weinstock, Joshua S , Bhattacharya, Romit , Ebert, Benjamin L , Natarajan, Pradeep , Yu, Zhi , Zekavat, Seyedeh M , Truong, Buu Minh Thanh , Haidermota, Sara , Honigberg, Michael C. , Zhang, Martin Jinye , Dron, Jacqueline S. , Heimlich, Jonathan Brett , Sankaran, Vijay G. , Griffin, Gabriel K. , Gibson, Christopher James , Wilson, Peter W.F. , Genovese, Giulio , Xu, Yaomin , Savona, Michael R. , Raffield, Laura M. , Arnett, Donna K. , Konkle, Barbara A. , Peyser, Patricia A. , Smith, Jennifer A. , Mathias, Rasika A. , Andrade, Mariza de , Darbar, Dawood , He, Jiang , Blangero, John , Weiss, Scott T. , Custer, Brian , Minster, Ryan L , Viali, Satupaitea , Mitchell, Braxton D. , Palmer, Nicholette D , Freedman, Barry I. , Bowden, Donald W. , Albert, Christine M. , Smith, Nicholas, Tracy, Russell P. , Psaty, Bruce M. , Taylor, Kent D. , Rotter, Jerome I. , Boerwinkle, Eric , Vasan, Ramachandran S. , Lubitz, Steven A. , Ellinor, Patrick T. , Loos, Ruth J. F. , Yun, Jeong H. , Cho, Michael H. , Abecasis, Gonçalo R. , Kooperberg, Charles , Reiner, Alex P. , Jaiswal, Siddhartha , Bick, Alexander G.

Mayo Clinic

No container title available | July 31, 2022 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1101/2022.07.29.22278015 Get It

Abstract With aging, somatic mutations in hematopoietic stem and progenitor cells (HSPC) can give rise to clonal hematopoiesis of indeterminate potential (CHIP), a premalignant state associated with diverse age-related diseases. Here we report the largest multi-ancestry genome-wide analysis of CHIP to date (N = 1,018,305), including individuals of African (N = 85,978), Admixed American (N = 191,371), East Asian (N = 13,532), European (N = 694,015), and South Asian (N = 13,193) ancestry. Multi-ancestry meta-analyses identified 72 genome-wide significant loci, including 44 novel associations implicating genes such as AFF1 , ATF7IP , ATP8B4 , BCL2 , CEBPA , CYRIA , DNM2 , ELF1 , NKX2-3 , PIK3CB , PRDM16 , RPN1 , TERC , and TRIM4 . Notably, variants at MECOM and PHF20L1 showed opposite allelic effects between DNMT3A - and non- DNMT3A -driven CHIP, highlighting driver-specific germline influences. Implicated loci converge on pathways regulating telomere maintenance, cell-cycle control, hematopoietic transcription, DNA damage response and immune signaling. These findings support a model in which germline variation both expands the HSPC pool and biases clonal selection in a driver-dependent manner, providing a mechanistic basis for inter-individual heterogeneity in CHIP. Phenome-wide association analyses further linked CHIP to hematologic, neoplastic, and circulatory traits, with enrichment across hematopoietic and non-hematopoietic cell types. Together, this work expands the genomic and phenomic landscape of CHIP and reveals germline–somatic interactions that shape clonal evolution during aging.